We investigated the family histories of 157 Japanese patients with probable or possible multiple system atrophy (MSA). A family history of neurodegenerative disorders was only detected in three MSA patients (1.9%). We evaluated these patients by careful neurological examination, neuroimaging studies, and genetic studies to exclude hereditary spinocerebellar ataxia with a similar clinical phenotype to MSA. The results indicated that one of them had a family history of MSA. Although the familial presence of neurodegenerative disorders is rare in MSA patients, the existence of such cases suggests that MSA may have a genetic background.
Introduction
Multiple system atrophy (MSA) is an adult-onset sporadic neurodegenerative disease that is clinically characterized by various combinations of poorly levodopa-responsive parkinsonism, cerebellar dysfunction, autonomic failure, and pyramidal tract involvement [1] . Neuropathologically, MSA is characterized by variable neuronal loss and gliosis in the putamen, substantia nigra, pontine nuclei, cereballar cortex, inferior olive, and intermediolateral column of the spinal cord. Particularly, characteristic neuropathology of MSA is the presence of glial cytoplasmic inclusions (GCIs) containing alpha-synuclein in the oligodendrocytes [2, 3] . Therefore MSA is classified as a member of "alpha-synucleinopathy" together with Lewy body disease and Parkinson's disease [3] . At present, the clinical diagnosis of MSA is based on the Consensus Criteria (Gilman et al, 1999 ) [1] . The aetiology of MSA is unknown and it is considered to be a sporadic disorder with onset in adulthood. However, a familial case of MSA was recently reported [4] and such familial occurrence has potential implications for the aetiology of this disorder. Therefore, we investigated the family histories of patients with MSA to detect any familial cases.
Patients and Methods
We retrospectively reviewed the medical records of 157 Japanese patients with Criteria except for the item of family history [1] . There were 78 men and 79 women.
One hundred and eighteen patients (75%) were classified as MSA-C (87 had probable MSA and 31 had possible MSA) and 39 patients were classified as MSA-P (13 had probable MSA and 26 had possible MSA). The mean age of onset was 57.7 ± 7.1 years (range: 38 -78 years).
Results and Case Reports
A family history of neurodegenerative disorders was only detected in 3 of the 157 MSA patients (1.9%). Patient 1 ("probable MSA-P") had a father who was diagnosed as having cortical cerebellar atrophy (CCA). Patient 2 ("probable MSA-C") had a mother who was diagnosed as having Parkinson's disease and Patient 3 ("probable MSA-P") had an uncle who was also diagnosed as having Parkinson's disease. Brain magnetic resonance imaging (MRI) showed a hyperintense rim at the dorsolateral border of the left putamen as well as atrophy of the brain stem and the cerebellum with a "hot cross bun" sign ( Fig.1-A, B ). She was diagnosed as having "possible MSA-P", and did not receive levodopa therapy. Over a four-year period from the onset, orthostatic hypotension gradually became worse and she was diagnosed as having "probable MSA-P" at the age of 61 years. Genetic testing excluded spinocerebellar ataxia (SCA) type1, 2, 3, 6, 8, 10, 12,14, and 17 as well as dentatorubral-pallidoluysian atrophy (DRPLA) and fragile X-associated tremor/ataxia syndrome (FXTAS).
Patient 1
Her father first noticed an unstable gait at the age of 65 years. He was referred to our hospital at the age of 70 years, by which time he showed ataxic dysarthria, ataxic gait, and ataxia of the trunk and limbs. No signs of parkinsonism or orthostatic hypotension were detected. Brain MRI showed mild cerebellar atrophy and a hyperintense rim at the dorsolateral border of the putamen without atrophy of the brain stem ( Fig.1-C, D) . At that time, he was tentatively diagnosed as having "CCA".
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However, he developed orthostatic hypotension after 6 months and showed extensor plantar responses 2 years later. At the age of 72 years, he was subsequently diagnosed as having "probable MSA-C". By 76 years old, he was unable to walk without a cane.
Because he switched to management by another hospital thereafter, we could no longer follow his clinical course in detail, but he died at the age of 83 years (18 years after the onset). Patient 1 had no first-or second-degree relatives with neurodegenerative disorders except for her father.
Patient 2
Patient 2 first noticed a clumsiness of his hands at the age of 46 years, and his gait became unstable at 47 years. His symptoms gradually got worse and he was admitted to our hospital when he was 48 years old. Neurological examination revealed ataxic dysarthria, gaze-evoked nystagmus, limb ataxia, and gait ataxia. However, there was no evidence of orthostatic hypotension，parkinsonism, or corticospinal tract dysfunction.
Brain MRI showed selective cerebellar atrophy and he was diagnosed as having "CCA" at that time. At the age of 50 years, he developed orthostatic hypotension，neurogenic bladder, and extensor plantar responses with hyperreflexia. MRI showed severe atrophy of the brain stem and cerebellum with a "hot cross bun" sign (not shown). Over a period of seven years after the onset, his orthostatic hypotension gradually worsened. He was diagnosed as having "probable MSA-C" when he was aged 53 years. Although the patient was confined to a wheelchair, he had no signs of parkinsonism. Genetic testing excluded SCA 1, 2, 3, 6, 8, 10, 12,14, and 17 as well as DRPLA and FXTAS.
His mother was diagnosed as having Parkinson's disease at the age of 74 years.
Her response to levodopa therapy was good and brain MRI did not show any abnormal findings. She died of gastric cancer at the age of 89 years. No cerebellar ataxia was observed throughout her clinical course.
Patient 3
Patient 3 noticed an unstable gait at the age of 65 years, and she was admitted to term "MSA" in 1969 [5, 6] . Because two members of this family had ataxia and parkinsonism in addition to orthostatic hypotension, they fulfilled the criteria for "probable-MSA", but they also developed muscle atrophy and other family members presented with claw foot and diarrhea. These symptoms are not common in MSA, so the family might have had another neurological disease. Wüllner et al. reported a German family with MSA in 2004 [4] . Two members of the family fulfilled the criteria for "probable MSA", and brain MRI showed changes that were typical of MSA. Patients with MSA and a family history of other neurodegenerative disorders were also rare in our series. However, a higher frequency of neurological symptoms and neurological diseases was reported in the first-degree relatives of 60 European MSA patients than in controls [8] . In that study, three patients (5%) had a parent or brother with parkinsonism. In another report, five out of 38 MSA patients (13%) had at least one first-degree or second-degree relative with parkinsonism [9] . In our series, two out of 157 MSA patients had a family history of Parkinson's disease. Kusumi et al. reported that the age-and sex-adjusted prevalence of Parkinson's disease was 99.5 per 100,000 population in Japan in 1992 [10] . Schrag et al. reported that the age-adjusted prevalence of MSA was 4.4 per 100,000 population in England [11] . Since the prevalence of Parkinson's disease was very much higher than that of MSA, it is entirely possible that in our two families Parkinson's disease occurred as an incidental phenomenon.
Discussion
However MSA is neuropathologically classified as a form of pathologically diagnosed as having Parkinson's disease [12] . The existence of such families might indicate a common mechanism underlying "alpha-synucleinopathy" that can present as MSA or Parkinson's disease.
Although MSA is still considered to be a sporadic disorder, a few families with a history of MSA and other neurodegenerative disorders do exist. This may indicate that MSA has a multigenetic aetiology. In addition, MSA-C was the most common manifestation in our study. One hundred and eighteen patients (75%) were classified as MSA-C in our 157 MSA patients. In the other report, 155 patients (67%) were classified as MSA-C in 230 Japanese MSA patients [13] . On the contrary, MSA-P was the most common manifestation in Europe [14] . The cause of this difference is unknown, but it is likely that some genetic factors may modify the clinical phenotype of MSA.
Recently, interleukin-1A, Interleukin-8, intercellular adhesion molecule-1 and tumor necrosis factor gene polymorphisms were reported to increase the risk of MSA [15] [16] [17] , but no association was found between MSA and polymorphism of the alpha-synuclein, synphilin, tau, APOE, and Fragile X genes [18] [19] [20] . Genetic analysis of families with MSA might shed more light on its genetic background. 
